Non-invasive efficient brain delivery of Prussian Blue for treatment of Alzheimer disease
Award amount
$1,459,774Program and phase
SBIR · Phase IIAward year
2020Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Weinberg Medical Holdings
- Proposal award date
- 2020-09-01
- Contract end date
- 2022-08-31
- UEI
- CACBXGF9BC17
- Solicitation number
- PAS18-187
- Topic code
- NIA
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A system to optimize surgery for servie members with back injury and expedite their return to work
- Non-invasive efficient brain delivery of Prussian Blue for treatment of Alzheimer disease
- Brain Targeting Nanoparticle for Drug Delivery in Traumatic Brain Injury
- Noninvasive placement and activation of deep-brain stimulating magnetic particles for reduction of drug-seeking behaviors
- Drug Delivery Method for Sudden Sensorineural Hearing Loss
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy Volunteers
- A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment
- VR-CARES: Feasibility of Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support to improve social connection, health, and at-home dementia care
- Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias
- Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease
Research funding history
28 SBIR/STTR records share this UEI (2007–2022). Reported award amounts total $23,808,895. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation, Department of Commerce, Department of Energy